InvestorsHub Logo
Followers 2431
Posts 91292
Boards Moderated 7
Alias Born 09/12/2003

Re: Beatcovid post# 914

Friday, 07/03/2020 4:38:05 PM

Friday, July 03, 2020 4:38:05 PM

Post# of 36600
Agreed! This is an easy calls: The FDA like Bucillamine they recommenced company summit IND for Phase 3 of course they going to approve it. "Revive in April filed a pre-investigational new drug meeting request with the FDA for Bucillamine for the treatment of Covid-19 to proceed to a Phase 2 clinical study. The FDA recommended that the company submit its IND for a Phase 3 confirmatory trial.